All Stories

  1. Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry

    Article • Journal of Pain Research, May 2019, Dove Medical Press

    Ute Essner

  2. Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies

    Article • Journal of Central Nervous System Disease, January 2019, SAGE Publications

    Professor Tjalf Ziemssen, Ute Essner

  3. Sativex® as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial

    Article • International Journal of Neuroscience, May 2018, Taylor & Francis

    Ute Essner

  4. Efficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trials

    Article • Journal of Pain Research, November 2016, Dove Medical Press

    Ute Essner